Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson symbols : Gmab save search
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -3.66%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.29%
H: 1.91%
C: 1.27%
darzalex sales first for
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.03%
H: 3.03%
C: 1.75%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: 2.12%
H: 0.6%
C: -2.54%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.19%
H: 0.47%
C: -0.77%
meeting
Genmab Publishes 2023 Annual Report
Published: 2024-02-14 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 2.65%
H: 4.56%
C: 1.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: 0.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.32%
H: 5.34%
C: 3.02%
report
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
Published: 2024-01-23 (Crawled : 12:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: -1.15%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: -0.29%
darzalex sales
Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen
Published: 2024-01-22 (Crawled : 00:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: -1.15%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: -0.29%
license agreement
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet therapy regimen shows significant improvement in outcomes for patients with transplant-eligible newly diagnosed multiple myeloma
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -4.43%
H: 0.76%
C: -0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -5.33%
H: 0.46%
C: 0.13%
faspro darzalex therapy
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023
Published: 2023-10-17 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -1.49%
H: 2.14%
C: -0.67%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.55%
H: 5.45%
C: 0.63%
darzalex sales
Genmab Announces Financial Results for the First Half of 2023
Published: 2023-08-03 (Crawled : 15:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.24%
H: 1.29%
C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.25%
H: 1.87%
C: 1.52%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.25%
H: 3.13%
C: 1.84%
financial results
Genmab Updates 2023 Financial Guidance
Published: 2023-07-27 (Crawled : 22:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.92%
H: 6.99%
C: 6.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.78%
C: 0.28%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.21%
H: 6.8%
C: 5.61%
financial
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2023
Published: 2023-07-20 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 2.05%
H: 0.91%
C: 0.87%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.1%
H: 0.73%
C: 0.24%
darzalex sales
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma
Published: 2023-06-03 (Crawled : 20:20) - prnewswire.com
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
response
Genmab Announces Financial Results for the First Quarter of 2023
Published: 2023-05-10 (Crawled : 14:20) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.92%
H: 0.54%
C: -0.64%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.03%
H: 0.26%
C: 0.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.09%
H: 0.48%
C: 0.28%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.15%
H: 2.12%
C: 1.79%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.6%
H: 1.64%
C: -0.39%
financial results
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen
Published: 2023-04-20 (Crawled : 00:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.53%
H: 1.41%
C: 1.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 0.32%
C: -1.06%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.1%
H: 0.96%
C: 0.64%
license agreement
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2023
Published: 2023-04-18 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -3.69%
H: 2.03%
C: 0.71%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.86%
H: 0.27%
C: -1.97%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.79%
H: 0.26%
C: -0.17%
darzalex sales
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2023-03-07 (Crawled : 14:00) - globenewswire.com
GRNA | $0.2995 -0.03% -0.07% 0
|
Professional, Scientific, and T...
|
| O: 3.93%
H: 6.0%
C: -0.42%
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -3.32%
H: 3.52%
C: 0.25%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.34%
H: 0.1%
C: -1.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -0.2%
H: 3.85%
C: 0.06%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.58%
H: 0.25%
C: -1.3%
meeting
Genmab Publishes 2022 Annual Report
Published: 2023-02-22 (Crawled : 17:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.51%
H: 1.17%
C: -0.9%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.98%
H: 0.03%
C: -1.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.45%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.66%
H: 0.76%
C: -0.22%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: -1.33%
H: 4.88%
C: 2.2%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.53%
H: 0.32%
C: -2.74%
report
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
Published: 2023-01-24 (Crawled : 12:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.19%
H: 0.0%
C: -2.93%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: -3.82%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.95%
H: 0.08%
C: -1.24%
darzalex sales
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Published: 2022-12-12 (Crawled : 18:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.4%
H: 2.59%
C: -1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.12%
H: 1.09%
C: 1.07%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.09%
H: 3.47%
C: 2.83%
darzalex results study
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Published: 2022-12-06 (Crawled : 17:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: -0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.64%
H: 0.04%
C: -2.12%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.49%
H: 0.12%
C: -2.25%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -2.98%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.11%
H: 0.02%
C: -1.74%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.48%
H: 1.59%
C: 0.69%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.33%
H: 0.56%
C: -0.89%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.